🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/10/2020 | 75,31 | 76,56 | 74,42 | 74,42 | -1,08% | 2,84% | 12.241.374 |
| 26/10/2020 | 75,70 | 76,15 | 74,68 | 75,23 | -1,24% | 1,94% | 9.122.840 |
| 23/10/2020 | 75,63 | 76,93 | 75,63 | 76,17 | +0,78% | 1,72% | 7.309.381 |
| 22/10/2020 | 74,52 | 75,81 | 74,52 | 75,58 | +1,46% | 1,73% | 6.075.990 |
| 21/10/2020 | 74,68 | 75,24 | 74,46 | 74,49 | -0,26% | 1,05% | 9.689.808 |
| 20/10/2020 | 75,35 | 75,35 | 74,50 | 74,69 | -0,51% | 1,13% | 11.144.746 |
| 19/10/2020 | 76,45 | 76,80 | 74,74 | 75,07 | -1,45% | 2,70% | 8.614.455 |
| 16/10/2020 | 75,67 | 76,62 | 75,49 | 76,17 | +0,97% | 1,50% | 7.903.492 |
| 15/10/2020 | 76,15 | 76,28 | 75,17 | 75,44 | -1,80% | 1,45% | 9.151.974 |
| 14/10/2020 | 77,15 | 77,22 | 76,40 | 76,82 | -0,25% | 1,06% | 9.166.122 |
| 13/10/2020 | 76,62 | 77,22 | 76,37 | 77,01 | +0,44% | 1,11% | 9.125.774 |
| 12/10/2020 | 76,82 | 77,02 | 76,25 | 76,68 | +0,00% | 1,01% | 8.276.370 |
| 09/10/2020 | 77,18 | 77,37 | 76,38 | 76,68 | -0,15% | 1,27% | 5.956.098 |
| 08/10/2020 | 76,71 | 78,08 | 76,49 | 76,79 | +0,55% | 2,08% | 9.217.160 |
| 07/10/2020 | 76,42 | 76,67 | 75,87 | 76,37 | +0,51% | 1,05% | 9.845.226 |
| 06/10/2020 | 77,41 | 77,42 | 75,88 | 75,98 | -1,98% | 2,00% | 10.273.230 |
| 05/10/2020 | 77,51 | 77,81 | 76,93 | 77,52 | +0,54% | 1,13% | 8.807.182 |
| 02/10/2020 | 77,10 | 78,00 | 76,77 | 77,10 | -1,03% | 1,60% | 5.255.406 |
| 01/10/2020 | 79,37 | 79,52 | 77,53 | 77,90 | -1,58% | 2,51% | 8.410.305 |
| 30/09/2020 | 78,49 | 79,50 | 78,26 | 79,15 | +1,28% | 1,58% | 11.593.605 |
| 29/09/2020 | 78,89 | 79,34 | 77,96 | 78,15 | -1,04% | 1,75% | 6.742.413 |
| 28/09/2020 | 79,39 | 79,87 | 78,78 | 78,97 | -0,20% | 1,37% | 6.123.674 |
| 25/09/2020 | 78,39 | 79,43 | 78,05 | 79,13 | -0,26% | 1,75% | 6.932.101 |
| 24/09/2020 | 78,34 | 79,66 | 78,10 | 79,34 | +0,63% | 1,99% | 7.844.280 |
| 23/09/2020 | 79,28 | 79,98 | 78,80 | 78,85 | -0,37% | 1,49% | 7.085.842 |
| 22/09/2020 | 79,29 | 79,74 | 78,44 | 79,14 | -0,23% | 1,65% | 8.143.170 |
| 21/09/2020 | 81,03 | 81,43 | 78,33 | 79,32 | -3,12% | 3,83% | 10.445.311 |
| 18/09/2020 | 81,65 | 82,35 | 81,05 | 81,88 | +0,20% | 1,59% | 12.308.446 |
| 17/09/2020 | 81,47 | 81,84 | 80,58 | 81,72 | +0,08% | 1,55% | 8.090.455 |
| 16/09/2020 | 80,63 | 82,16 | 80,63 | 81,65 | +1,61% | 1,89% | 10.380.230 |